前立腺腫瘍における血清脂質動態に関する臨床的研究 : 第2報前立腺癌患者に対する estramustine phosphate disodium, hexestrol および diethylstilbestrol 4,4-diphosphoric ester 投与による血清脂質値およびリポ蛋白分画の変動について

概要

論文の詳細を見る
Twenty-three patients with prostatic cancer were treated with estramustine phosphate disodium (Estracyt), hexestrol(Hexron) and diethylstilbestrol 4,4-diphosphoric ester(Honvan). Sixteen cases were given 560 to 840mg of Estracyt, 6 cases 30mg of Hexron and 1 case 200mg of Honvanorally daily. Fasting serum lipids and lipoprotein fractions were measured before and during the treatment with these drugs. Furthermore, in 3 patients with benign prostatic hypertrophy who were tried with the administration of 100mg per day of Honvan orally, changes of fasting serum lipids were studied.
社団法人日本泌尿器科学会の論文